Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay-Reference-Cited by-同舟云学术

Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay

Published:2019-07 Issue:7 Volume:63 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Converse Paul J.¹,Almeida Deepak V.¹,Tyagi Sandeep¹,Xu Jian¹,Nuermberger Eric L.¹

Affiliation:

1. Department of Medicine, Johns Hopkins University Center for Tuberculosis Research, Baltimore, Maryland, USA

Abstract

Buruli ulcer is treatable with antibiotics. An 8-week course of rifampin (RIF) and either streptomycin (STR) or clarithromycin (CLR) cures over 90% of patients.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00426-19

Reference39 articles.

1. Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial

2. Antibiotic complications during the treatment ofMycobacterium ulceransdisease in Australian patients

3. Clarithromycin extended-release in community-acquired respiratory tract infections

4. Therapeutic Drug Monitoring in the Treatment ofMycobacterium aviumComplex Lung Disease

5. The Pharmacokinetics and Pharmacodynamics of PulmonaryMycobacterium aviumComplex Disease Treatment

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycobacterium ulcerans challenge strain selection for a Buruli ulcer controlled human infection model;PLOS Neglected Tropical Diseases;2024-05-03

2. Bedaquiline for treatment of non-tuberculous mycobacteria (NTM): a systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2023-12-22

3. Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease;CHIMIA;2023-09-20

4. The Many Hosts of Mycobacteria 9 (MHM9): A conference report;Tuberculosis;2023-09

5. Can membrane composition traffic toxins? Mycolactone and preferential membrane interactions;Biophysical Journal;2022-11